Document:

THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THIS WARRANT
AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT OR ANY APPLICABLE
STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ON
THE GO HEALTHCARE, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

  Right to Purchase XXX shares of Common Stock of On the Go Healthcare, Inc.
                 (subject to adjustment as provided herein)

               FORM OF SERIES C COMMON STOCK PURCHASE WARRANT

                       Issue Date: November x, 2004

ON THE GO HEALTHCARE, INC., a corporation organized under the laws of the State
of Delaware (the "Company"), hereby certifies that, for value received, HOLDER,
or its assigns (the "Holder"), is entitled, subject to the terms set forth
below, to purchase from the Company at any time after the Issue Date until
5:00 p.m., E.S.T on October 31, 2006 (the "Expiration Date"), up to XXX  fully
paid and nonassessable shares of the common stock of the Company (the "Common
Stock"), $0.0001 par value per share, at a purchase price equivalent to $1.00
per share of common stock ("Purchase Price").  The number and character of such
shares of Common Stock and the Purchase Price are subject to adjustment as
provided herein.  The Company may reduce the Purchase Price without the consent
of the Holder.  The Company may, in its sole discretion, extend the Expiration
Date.

As used herein the following terms, unless the context otherwise requires, have
the following respective meanings:

      (a)  The term "Company" shall include On the Go Healthcare, Inc. and any
           corporation which shall succeed or assume the obligations of On the
           Go Healthcare, Inc. hereunder.

      (b)  The term "Common Stock" includes (a) the Company's Common Stock,
           $0.0001 par value per share, and (b) any other securities into which
           or for which any of the securities described in (a) may be converted
           or exchanged pursuant to a plan of recapitalization, reorganization,
           merger, sale of assets or otherwise.

      (c)  The term "Other Securities" refers to any stock (other than Common
           Stock) and other securities of the Company or any other person
           (corporate or otherwise) which the holder of the Warrant at any time
           shall be entitled to receive, or shall have received, on the
           exercise of the Warrant, in lieu of or in addition to Common Stock,
           or which at any time shall be issuable or shall have been issued in
           exchange for or in replacement of Common Stock or Other Securities
           pursuant to Section 3 or otherwise.

  1.  Exercise of Warrant.

1.1.  Number of Shares Issuable upon Exercise.  From and after the Issue Date
      through and including the Expiration Date, the Holder hereof shall be
      entitled to receive, upon exercise of this Warrant in whole in accordance
      with the terms of this Section, subject to adjustment pursuant to
      Section 3.

1.2   Limitations on Conversion.  This Warrant can not be exercised so that the
      Holder will own more than 4.99% of the Company's Common Stock.  The
      Holder may exercise this Warrant in part in compliance with Section 1.4
      below in order to comply with this requirement.  Additionally, the Holder
      may not purchase more than 9.99% of the Company's stock within a thirty
      day period.

<PAGE>

1.3.  Full Exercise.  This Warrant may be exercised in full by the Holder
      hereof by delivery of an original or facsimile copy of the Form of
      Election to Purchase attached as Exhibit A hereto duly executed by such
      Holder and surrender of the original Warrant within seven (7) days of
      exercise, to the Company at its principal office or at the office of
      its Warrant Agent (as provided hereinafter), accompanied by payment,
      in cash, wire transfer or by certified or official bank check payable
      to the order of the Company, in the amount obtained by multiplying the
      number of shares of Common Stock for which this Warrant is then
      exercisable by the Purchase Price.

1.4.  Partial Exercise.  This Warrant may be exercised in part (but not for
      a fractional share) by surrender of this Warrant in the manner and at the
      place provided in subsection 1.2 except that the amount payable by the
      Holder on such partial exercise shall be the amount obtained by
      multiplying (a) the number of whole shares of Common Stock designated
      by the Holder in the Subscription Form by (b) the Purchase Price.  On
      any such partial exercise, the Company, at its expense, will forthwith
      issue and deliver to or upon the order of the Holder hereof a new Warrant
      of like tenor, in the name of the Holder hereof or as such Holder (upon
      payment by such Holder of any applicable transfer taxes) may request,
      the whole number of shares of Common Stock for which such Warrant may
      still be exercised.

1.5.  Fair Market Value. Fair Market Value of a share of Common Stock as of a
      particular date (the "Determination Date") shall mean:

      (a) If the Company's Common Stock is traded on the New York Stock
          Exchange, the American Stock Exchange or any other national exchange
          or is quoted on the National Association of Securities Dealers, Inc.
          Automated Quotation ("NASDAQ"), National Market System or the NASDAQ
          SmallCap Market, then the closing or last sale price, respectively,
          reported for the last business day immediately preceding the
          Determination Date;

      (b) If the Company's Common Stock is not traded on the New York Stock
          Exchange, the American Stock Exchange or any other national exchange
          and is not quoted on the NASDAQ National Market System or the NASDAQ
          SmallCap Market, but is traded in the Over-the-Counter market, then
          the average of the closing bid and ask prices reported for the last
          business day immediately preceding the Determination Date;

      (c)  Except as provided in clause (d) below, if the Company's Common
           Stock is not publicly traded, then as the Holder and the Company
           agree, or in the absence of such an agreement, by arbitration in
           accordance with the rules then standing of the American Arbitration
           Association, before a single arbitrator to be chosen from a panel of
           persons qualified by education and training to pass on the matter to
           be decided; or

      (d)  If the Determination Date is the date of a liquidation, dissolution
           or winding up, or any event deemed to be a liquidation, dissolution
           or winding up pursuant to the Company's charter, then all amounts to
           be payable per share to holders of the Common Stock pursuant to the
           charter in the event of such liquidation, dissolution or winding up,
           plus all other amounts to be payable per share in respect of the
           Common Stock in liquidation under the charter, assuming for the
           purposes of this clause (d) that all of the shares of Common Stock
           then issuable upon exercise of all of the Warrants are outstanding
           at the Determination Date.

<PAGE>

1.6.  Trustee for Warrant Holders. In the event that a bank or trust company
      shall have been appointed as trustee for the Holder of the Warrants
      pursuant to Subsection 2.2, such bank or trust company shall have all the
      powers and duties of a warrant agent (as hereinafter described) and shall
      accept, in its own name for the account of the Company or such successor
      person as may be entitled thereto, all amounts otherwise payable to the
      Company or such successor, as the case may be, on exercise of this
      Warrant pursuant to this Section 1.

1.7   Delivery of Stock Certificates, etc. on Exercise. The Company agrees that
      the shares of Common Stock purchased upon exercise of this Warrant shall
      be deemed to be issued to the Holder hereof as the record owner of such
      shares as of the close of business on the date on which this Warrant
      shall have been surrendered and payment made for such shares as
      aforesaid. As soon as practicable after the exercise of this Warrant in
      full or in part, and in any event within seven (7) days thereafter, the
      Company will cause to be issued in the name of and delivered to the
      Holder hereof, or as such Holder (upon payment by such Holder of any
      applicable transfer taxes) may direct in compliance with applicable
      securities laws, a certificate or certificates for the number of duly
      and validly issued, fully paid and nonassessable shares of Common Stock
      (or Other Securities) to which such Holder shall be entitled on such
      exercise, plus, in lieu of any fractional share to which such Holder
      would otherwise be entitled, cash equal to such fraction multiplied by
      the then Fair Market Value of one full share of Common Stock, together
      with any other stock or other securities and property (including cash,
      where applicable) to which such Holder is entitled upon such exercise
      pursuant to Section 1 or otherwise.

  2.  Adjustment for Reorganization, Consolidation, Merger, etc.

2.1.  Reorganization, Consolidation, Merger, etc.  In case at any time or
      from time to time, the Company shall (a) effect a reorganization,
      (b) consolidate with or merge into any other person or (c) transfer
      all or substantially all of its properties or assets to any other person
      under any plan or arrangement contemplating the dissolution of the
      Company, then, in each such case, as a condition to the consummation
      of such a transaction, proper and adequate provision shall be made by
      the Company whereby the Holder of this Warrant, on the exercise hereof
      as provided in Section 1, at any time after the consummation of such
      reorganization, consolidation or merger or the effective date of such
      dissolution, as the case may be, shall receive, in lieu of the Common
      Stock (or Other Securities) issuable on such exercise prior to such
      consummation or such effective date, the stock and other securities
      and property to which such Holder would have been entitled upon such
      consummation or in connection with such dissolution, as the case may
      be, if such Holder had so exercised this Warrant, immediately prior
      thereto, all subject to further adjustment thereafter as provided in
      Section 3.

2.2.  Dissolution.  In the event of any dissolution of the Company following
      the transfer of all or substantially all of its properties or assets,
      the Company, prior to such dissolution, shall at its expense deliver
      or cause to be delivered the stock and other securities and property
      receivable by the Holder of the Warrants after the effective date of
      such dissolution pursuant to this Section 2 to a bank or trust company
      (a "Trustee"), as trustee for the Holder of the Warrants.

<PAGE>

2.3.  Continuation of Terms.  Upon any reorganization, consolidation, merger
      or transfer (and any dissolution following any transfer) referred to
      in this Section 2, this Warrant shall continue in full force and effect
      and the terms hereof shall be applicable to the Other Securities and
      property receivable on the exercise of this Warrant after the
      consummation of such reorganization, consolidation or merger or the
      effective date of dissolution following any such transfer, as the case
      may be, and shall be binding upon the issuer of any Other Securities,
      including, in the case of any such transfer, the person acquiring all
      or substantially all of the properties or assets of the Company.  In
      the event this Warrant does not continue in full force and effect
      after the consummation of the transaction described in this Section 2,
      then only in such event will the Company's securities and property
      (including cash, where applicable) receivable by the Holder of the
      Warrants be delivered to the Trustee as contemplated by Section 2.2.

  3.  Extraordinary Events Regarding Common Stock.  In the event that the
      Company shall (a) issue additional shares of the Common Stock as a
      dividend or other distribution on outstanding Common Stock, (b) subdivide
      its outstanding shares of Common Stock, or (c) combine its outstanding
      shares of the Common Stock into a smaller number of shares of the Common
      Stock, then, in each such event, the Purchase Price shall, simultaneously
      with the happening of such event, be adjusted by multiplying the then
      Purchase Price by a fraction, the numerator of which shall be the number
      of shares of Common Stock outstanding immediately prior to such event
      and the denominator of which shall be the number of shares of Common
      Stock outstanding immediately after such event, and the product so
      obtained shall thereafter be the Purchase Price then in effect. The
      Purchase Price, as so adjusted, shall be readjusted in the same manner
      upon the happening of any successive event or events described herein
      in this Section 3. The number of shares of Common Stock that the Holder
      of this Warrant shall thereafter, on the exercise hereof as provided in
      Section 1, be entitled to receive shall be adjusted to a number
      determined by multiplying the number of shares of Common Stock that
      would otherwise (but for the provisions of this Section 3) be issuable
      on such exercise by a fraction of which (a) the numerator is the Purchase
      Price that would otherwise (but for the provisions of this Section 3) be
      in effect, and (b) the denominator is the Purchase Price in effect on the
      date of such exercise.

  4.  Reservation of Stock, etc. Issuable on Exercise of Warrant; Financial
      Statements.   The Company will at all times reserve and keep available,
      solely for issuance and delivery on the exercise of the Warrants, all
      shares of Common Stock (or Other Securities) from time to time issuable
      on the exercise of the Warrant.

<PAGE>

  5.  Assignment; Exchange of Warrant.  Subject to compliance with applicable
      securities laws, this Warrant, and the rights evidenced hereby, may be
      transferred by any registered holder hereof (a "Transferor"). On the
      surrender for exchange of this Warrant, with the Transferor's endorsement
      attached hereto (the "Transferor Endorsement Form") and together with an
      opinion of counsel reasonably satisfactory to the Company that the
      transfer of this Warrant will be in compliance with applicable securities
      laws, the Company, twice, only, but with payment by the Transferor of
      any applicable transfer taxes, will issue and deliver to or on the order
      of the Transferor thereof a new Warrant or Warrants of like tenor, in the
      name of the Transferor and/or the transferee(s) specified in such
      Transferor Endorsement Form (each a "Transferee"), calling in the
      aggregate on the face or faces thereof for the number of shares of
      Common Stock called for on the face or faces of the Warrant so
      surrendered by the Transferor.

  6.  Replacement of Warrant.  On receipt of evidence reasonably satisfactory
      to the Company of the loss, theft, destruction or mutilation of this
      Warrant and, in the case of any such loss, theft or destruction of this
      Warrant, on delivery of an indemnity agreement or security reasonably
      satisfactory in form and amount to the Company or, in the case of any
      such mutilation, on surrender and cancellation of this Warrant, the
      Company at the Holder's expense, twice only, will execute and deliver,
      in lieu thereof, a new Warrant of like tenor.

  7.  Call. The Company shall have the option to "call" the Warrant in
      accordance with and governed by the following:

      (a)  The Company shall exercise the Warrant Call by giving to the Warrant
           Holder a written notice of call (the "Call Notice") during the
           period in which the Warrant Call may be exercised.  The effective
           date of each Call Notice (the "Call Date") is the date on which
           notice is effective under the notice provision of Section 10 of
           this Warrant.

      (b)  The Company's right to exercise the Warrant Call shall commence
           thirty trading days after the effective date of a registration
           statement covering the resale of the shares of Common Stock
           underlying this Warrant.

      (c)  The number of shares of Common Stock to be issued upon exercise
           of the Warrant which are subject to a Call Notice must be registered
           in a registration statement effective from twenty-two trading days
           prior to the Call Date and through the Delivery Date.

      (d)  A Call Notice may be given not sooner than thirty trading days
           after the prior Call Date.

      (e)  A Call Notice may be given by the Company only within five trading
           days after the Common Stock has had a closing price as reported for
           the Principal Market of not less than one hundred and fifty percent
           (150%) of the Purchase Price for ten (10) consecutive trading days
           ("Lookback Period").

      (f)  The Common Stock must be listed on the Principal Market for the
           Lookback Period and through the Delivery Date.

<PAGE>

      (g)  The Company shall not have received a notice from the Principal
           Market during the ninety calendar days prior to the Call Date that
           the Company or the Common Stock does not meet the requirements for
           continued quotation, listing or trading on the Principal Market.

      (h)  The Company and the Common Stock shall meet the requirements for
           continued quotation, listing or trading on the Principal Market
           for the Lookback Period and through the Delivery Date.

      (i)  The Warrant Holder shall exercise his Warrant rights and purchase
           the Called Common Stock and pay for same within thirty (30) days
           after the Call Date.  If the Warrant Holder fails to timely pay the
           amount required by the Warrant Call, the Company's sole remedy shall
           be to cancel a corresponding amount of this Warrant.

      (j)  The Company may not exercise the right to Call this Warrant after
           the occurrence of a default by the Company of a material term of
           this Warrant.

  8.  Warrant Agent.  The Company may, by written notice to the Holder of the
      Warrant, appoint an agent (a "Warrant Agent") for the purpose of issuing
      Common Stock (or Other Securities) on the exercise of this Warrant
      pursuant to Section 1, exchanging this Warrant pursuant to Section 5,
      and replacing this Warrant pursuant to Section 6, or any of the
      foregoing, and thereafter any such issuance, exchange or replacement,
      as the case may be, shall be made at such office by such Warrant Agent.

  9.  Transfer on the Company's Books.  Until this Warrant is transferred on
      the books of the Company, the Company may treat the registered holder
      hereof as the absolute owner hereof for all purposes, notwithstanding
      any notice to the contrary.

 10.  Notices.  All notices, demands, requests, consents, approvals, and other
      communications required or permitted hereunder shall be in writing and,
      unless otherwise specified herein, shall be (i) personally served,
      (ii) deposited in the mail, registered or certified, return receipt
      requested, postage prepaid, (iii) delivered by reputable air courier
      service with charges prepaid, or (iv) transmitted by hand delivery,
      telegram, or facsimile, addressed as set forth below or to such other
      address as such party shall have specified most recently by written
      notice.  Any notice or other communication required or permitted to
      be given hereunder shall be deemed effective (a) upon hand delivery or
      delivery by facsimile, with accurate confirmation generated by the
      transmitting facsimile machine, at the address or number designated below
      (if delivered on a business day during normal business hours where such
      notice is to be received), or the first business day following such
      delivery (if delivered other than on a business day during normal
      business hours where such notice is to be received) or (b) on the second
      business day following the date of mailing by express courier service,
      fully prepaid, addressed to such address, or upon actual receipt of such
      mailing, whichever shall first occur.  The addresses for such
      communications shall be:

        (i) if to the Company to:
            On The Go Healthcare, Inc.
            85 Corstate Avenue, Unit #1
            Concord, Ontario, Canada L4K 4Y2
            Phone: (905) 760-2987
              Fax: (905) 660-5738

<PAGE>

        with a copy to:

            Amy Trombly,
            1163 Walnut Street, Suite 7,
            Newton, Massachusetts 02461
            Phone: (617) 243-0060
            Fax:  (309) 406-1426

       (ii) if to the Holder, to the address and fax number listed on the
            first paragraph of this Warrant, with a copy to:

11.  Miscellaneous.  This Warrant and any term hereof may be changed, waived,
     discharged or terminated only by an instrument in writing signed by the
     party against which enforcement of such change, waiver, discharge or
     termination is sought. This Warrant shall be construed and enforced in
     accordance with and governed by the laws of New York.  Any dispute
     relating to this Warrant shall be adjudicated in the State of New York.
     The headings in this Warrant are for purposes of reference only, and
     shall not limit or otherwise affect any of the terms hereof.  The
     invalidity or unenforceability of any provision hereof shall in no way
     affect the validity or enforceability of any other provision.

     IN WITNESS WHEREOF, the Company has executed this Warrant as of the
     date first written above.

     ON THE GO HEALTHCARE, INC.

     By:
     Name:
     Title:

Witness:

<PAGE>

EXHIBIT A

FORM OF ELECTION TO PURCHASE

(To be executed by the Holder to exercise the right to purchase shares of
 Common Stock  under  the  foregoing  Warrant)

To:  On the Go Healthcare, Inc.:

In  accordance  with  the  Warrant  enclosed  with this Form of Election to
Purchase,  the  undersigned hereby irrevocably elects to purchase  ____________
shares of Common Stock ("Common Stock"), of On the Go Healthcare, Inc.,  and,
encloses herewith $________ in cash, certified  or  official bank check or
checks, which sum represents the aggregate Exercise  Price  (as  defined in
the Warrant) for the number of shares of Common Stock  to  which  this  Form
of Election to Purchase relates, together with any applicable  taxes  payable
by  the  undersigned  pursuant  to  the  Warrant.

     The  undersigned  requests that certificates for the shares of Common
Stock issuable  upon  this  exercise  be  issued  in  the  name  of:  _________
_________________(please  print  name  and  address).   Social Security or Tax
Identification number: ____________________

If  the  number of shares of Common Stock issuable upon this exercise shall
not  be  all  of the shares of Common Stock which the undersigned is entitled
to purchase  in accordance with the enclosed Warrant, the undersigned requests
that a  New  Warrant (as defined in the Warrant) evidencing the right to
purchase the shares of Common Stock not issuable pursuant to the exercise
evidenced hereby be issued  in the name of and delivered  to:  (Please  print
name  and  address)

Dated:  _________________               Name  of  Holder:______________________

(By:)
(Name:)
(Title:)
(Signature must conform in all respects to name of holder as specified on the
face of the Warrant)

<PAGE>RESOLUTION AGREEMENT [5 PAGES TOTAL]

      THE  FOLLOWING  PARTIES Mr. John Taggart  individually  and Family  Health
News,  Inc., a Florida  corporation,  a/k/a "The Family Health News," a/k/a "The
Family  News,"  a/k/a "The Family  News,  Inc."  hereinafter  First  Parties and
GeneThera, Inc., a publicly traded Florida corporation, and including Hand Brand
Distribution,  Inc. a Florida corporation,  and GeneThera, Inc. f/k/a Hand Brand
Distribution,  Inc.  a Florida  corporation,  and  GeneThera,  Inc.  a  Colorado
corporation hereinafter referred to collectively as Second Party all do mutually
and fully agree as follows:

      WHEREAS  certain  heretofore   unresolved  ownership  and  stock  contract
disputes exist between the First Parties and the Second Party, and

      WHEREAS all parties  desire to resolve all  existing  unresolved  disputes
amicably and economically without resort to the Courts, and

      WHEREAS  in  consideration  the  resolution  of all  outstanding  disputes
between  First  Parties and Second Party in exchange  for 80,000  shares (in two
certificates  of 40,000 shares each) of GeneThera,  Inc.  (GTHA) from the Second
Party to the First Parties and the formal unconditional  transfer and release of
all  ownership  to Mr.  John  Taggart of Family  Health  News,  Inc.,  a Florida
corporation, a/k/a "The Family Health News," a/k/a "The Family News," a/k/a "The
Family News, Inc." and

      WHEREAS  in  consideration  the  resolution  of all  outstanding  disputes
between Second Party and First Parties in exchange for the formal  unconditional
transfer of all ownership from First Parties to Second Party of all ownership in
Hand Brand Distribution,  Inc. a Florida corporation, except as to the retention
by Mr. John  Taggart of all  ownership in Family  Health  News,  Inc., a Florida
corporation, a/k/a "The Family Health News," a/k/a "The Family News," a/k/a "The
Family News, Inc." and the resolution of the stock contract disputes, and

      WHEREAS all parties agree to cooperate expeditiously with each other, time
being  of the  essence,  with  the  exchange  of  financial  information  to and
cooperation with GeneThera's accountants Kantor, Sewell & Oppenheimer, P.A., and

                                        1
<PAGE>

      WHEREAS all parties agree to exchange separate Mutual General Releases, as
specified in Exhibits 1 and 2, and

      ALL PARTIES DO HEREBY represent, warrant, covenant and agree as follows to
the following terms and conditions:

      1. Second Party shall forthwith deliver the  aforementioned  80,000 common
shares of  GeneThera,  Inc.  (GTHA)  in the name of Mr.  John  Taggart  to First
Parties' attorney Gary Barcus,  Esq., to be held in escrow pending the execution
of these  separate  Mutual General  Releases.  These 80,000 common shares are to
satisfy all outstanding  convertible  notes.  The 80,000 common shares are to be
held in escrow until the 2003 audit of Family Health News,  Inc. is completed by
Steve Grubner and Genethera's  accountants  Kantor,  Sewell & Oppenheimer,  P.A.
(who will enjoy Mr. John Taggart's full  cooperation in audit  preparation),  or
GeneThera,  Inc.  files its most recently due 10Q filing with the Securities and
Exchange  Commission,  or until August 15, 2004, at the latest,  whichever event
occurs first, after which they shall be delivered to Mr. John Taggart.

      2. Second Party  acknowledges  that Family  Health  News,  Inc., a Florida
corporation, a/k/a "The Family Health News," a/k/a "The Family News," a/k/a "The
Family  News,  Inc." is owned in the name of Mr. John  Taggart and Second  Party
releases  and  conveys all  interests  in same,  if any,  to Mr.  John  Taggart,
unconditionally and in perpetuity, without any exception.

      3. Second  Party shall  forthwith  deliver  all records and  evidences  of
ownership of Family Health News, Inc., a Florida corporation,  a/k/a "The Family
Health  News," a/k/a "The Family  News," a/k/a "The Family News,  Inc." to First
Parties' attorney Gary Barcus,  Esq., to be held in escrow pending the execution
and delivery of these separate Mutual General Releases.

      4. First  Parties  shall  forthwith  deliver all records and  evidences of
ownership  of Hand  Brand  Distribution,  Inc. a Florida  corporation  to Second
Party's  attorney  Richard  Bryans,  Esq.,  to be held  in  escrow  pending  the
execution and delivery of these separate Mutual General Releases.

      5. All parties agree to supply and furnish  additional  documentations and
information to each other,  the provision all of which shall not be unreasonably
withheld, again, time being of the essence.

                                        2
<PAGE>

      6. In the event of default, all parties shall bear their own attorney fees
and costs, and litigation may be instituted by any party  exclusively in a court
of competent jurisdiction in Miami-Dade County, Florida. These instruments shall
be construed in favor of First Parties.

      7. The  respective  signatories  to this  Resolution  Agreement and to the
respective  First Mutual General  Release  (Exhibit 1) and Second Mutual General
Release (Exhibit 2) represent and warrant that they are specifically  authorized
and empowered to enter into all of these agreements and to bind their respective
parties with their signatures.

      UNDERSTOOD  AND AGREED TO August ____,  2004,  effective  nunc pro tunc to
October 1, 2003, by the  undersigned  who warrant and  represent  that they have
authority to sign and bind the respective parties:

                                                 -------------------------------
                                                 Dr. Antonio Milici, President
                                                 and CEO, GeneThera, Inc. (GTHA)

------------------------------                   -------------------------------
Mr. John Taggart, Individually                   Mr. John Taggart,President and
                                                 CEO, Family Health News, Inc.

                                        3
<PAGE>

                           FIRST MUTUAL GENERAL RELEASE

      KNOW ALL MEN BY THESE PRESENTS That the  undersigned,  GeneThera,  Inc., a
publicly traded Florida corporation, and including Hand Brand Distribution, Inc.
a Florida corporation, and GeneThera, Inc. f/k/a Hand Brand Distribution, Inc. a
Florida  corporation,  and GeneThera,  Inc. a Colorado  corporation  hereinafter
referred to collectively as Second Party, for and in consideration of $10.00 and
other  valuable  consideration  from Mr. John  Taggart  individually  and Family
Health News, Inc., a Florida corporation,  a/k/a "The Family Health News," a/k/a
"The Family News," a/k/a "The Family News, Inc." hereinafter First Parties,  and
with other good and valuable consideration received from the First Parties, does

      HEREBY remise,  release,  acquit,  satisfy, and forever discharge the said
First Parties and their heirs, personal representatives, successors and assigns,
subsidiaries,  affiliates,  employees,  officers,  directors,  shareholders  and
agents, of and from all, and all manner of action and actions,  cause and causes
of action,  suits,  debts,  dues, sums of money,  accounts,  reckonings,  bonds,
bills, specialties,  covenants,  contracts,  controversies,  claims, agreements,
promises,  variances,  trespasses,  damages, judgments,  executions, and demands
whatsoever,  in law or in equity,  which the Second  Party ever had, now has, or
which any  successor  or assign of said Second Party ever had, now has, or which
any successor or assign of said Second Party,  hereafter can, shall or may have,
against said First Parties and their heirs, personal representatives, successors
and  assigns,   subsidiaries,   affiliates,   employees,   officers,  directors,
shareholders,  and  agents  as the case may be,  for,  upon or by  reason of any
matter,  cause or thing whatsoever,  from the beginning of the world to the date
hereof.

      IN  WITNESS  HEREOF,  I have  set my hand  and  seal  August  ____,  2004,
effective nunc pro tunc to October 1, 2003.

                                               ---------------------------------
                                               Dr. Antonio Milici, President and
                                               CEO GeneThera, Inc. (GTHA)
STATE OF COLORADO
COUNTY OF _______________

      The foregoing instrument was acknowledged before me on August _____, 2004,
by Dr. Antonio  Milici,  as President an CEO of GeneThera,  Inc. who did take an
oath,  is personally  known to me or has produced the following  identification:

______________________________________________________________.

      WITNESS my hand and official  seal in the County and State last  aforesaid
on August ____, 2004.

                                                          ______________________
                                                          Colorado Notary Public

                                    EXHIBIT 1

                                       4
<PAGE>

                          SECOND MUTUAL GENERAL RELEASE

      KNOW ALL MEN BY THESE  PRESENTS  That the  undersigned,  Mr. John  Taggart
individually  and Family Health News,  Inc., a Florida  corporation,  a/k/a "The
Family  Health  News," a/k/a "The Family  News,"  a/k/a "The Family News,  Inc."
hereinafter First Parties, for and in consideration of $10.00 and other valuable
consideration from GeneThera,  Inc., a publicly traded Florida corporation,  and
including Hand Brand Distribution,  Inc. a Florida  corporation,  and GeneThera,
Inc. f/k/a Hand Brand Distribution,  Inc. a Florida corporation,  and GeneThera,
Inc. a Colorado  corporation  referred  to  hereinafter  collectively  as Second
Party, and with other good and valuable  consideration  received from the Second
Party, does

      HEREBY remise,  release,  acquit,  satisfy, and forever discharge the said
Second Party and their heirs, personal representatives,  successors and assigns,
subsidiaries,  affiliates,  employees,  officers,  directors,  shareholders  and
agents, of and from all, and all manner of action and actions,  cause and causes
of action,  suits,  debts,  dues, sums of money,  accounts,  reckonings,  bonds,
bills, specialties,  covenants,  contracts,  controversies,  claims, agreements,
promises,  variances,  trespasses,  damages, judgments,  executions, and demands
whatsoever,  in law or in equity,  which the First Parties ever had, now has, or
which any  successor or assign of said First Parties ever had, now has, or which
any successor or assign of said First Parties, hereafter can, shall or may have,
against said Second Party and their heirs, personal representatives,  successors
and  assigns,   subsidiaries,   affiliates,   employees,   officers,  directors,
shareholders,  and  agents  as the case may be,  for,  upon or by  reason of any
matter,  cause or thing whatsoever,  from the beginning of the world to the date
hereof.  IN  WITNESS  HEREOF,  I have set my hand and seal  August  ____,  2004,
effective nunc pro tunc to October 1, 2003.

------------------------------               -----------------------------------
Mr. John Taggart, Individually               Mr. John Taggart, President and CEO
                                             Family Health News, Inc.
STATE OF FLORIDA
COUNTY OF MIAMI-DADE

      The foregoing instrument was acknowledged before me on August _____, 2004,
by Mr. John  Taggart,  as President an CEO of Family  Health News,  Inc. and Mr.
John Taggart Individually who did take an oath, is personally known to me or has
produced the following identification: _____________________________________.

      WITNESS my hand and official  seal in the County and State last  aforesaid
on August ____, 2004.

                                                     ---------------------------
                                                     Florida Notary Public

                                    EXHIBIT 2

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]